These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21748351)

  • 1. Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.
    Polat ZA; Obwaller A; Vural A; Walochnik J
    Parasitol Res; 2012 Feb; 110(2):515-20. PubMed ID: 21748351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
    Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
    Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Topical Miltefosine in Patients with Acanthamoeba Keratitis: A Pilot Study.
    Bagga B; Joseph J; Garg P; Chandran K; Jayabhasker P; Manjulatha K; Sharma S
    Ophthalmology; 2019 May; 126(5):768-770. PubMed ID: 30572075
    [No Abstract]   [Full Text] [Related]  

  • 4. A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
    Vasseneix C; Gargala G; François A; Hellot MF; Duclos C; Muraine M; Benichou J; Ballet JJ; Brasseur G; Favennec L
    Cornea; 2006 Jun; 25(5):597-602. PubMed ID: 16783150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis.
    Dewan N; Ming W; Holland SP; Yeung SN; Iovieno A
    Cornea; 2019 Jul; 38(7):914-917. PubMed ID: 31170106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].
    Walochnik J; Duchêne M; Eibl H; Aspöck H
    Wien Klin Wochenschr; 2003; 115 Suppl 3():10-7. PubMed ID: 15508774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of
    Avdagic E; Chew HF; Veldman P; Tu EY; Jafri M; Doshi R; Boggild AK; Reidy JJ; Farooq AV
    Ocul Immunol Inflamm; 2021 Feb; 29(2):278-281. PubMed ID: 31829774
    [No Abstract]   [Full Text] [Related]  

  • 8. [Successful Treatment of Therapy-refractory Acanthamoeba Keratitis with Systemic Miltefosine and Topical Voriconazole].
    Schwarzer P; Blaser F; Sellner M; Rauthe SC; Tandogan T; Tappeiner C; Goldblum D
    Klin Monbl Augenheilkd; 2024 Apr; 241(4):406-408. PubMed ID: 38653269
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical treatment for combined Fusarium and Acanthamoeba keratitis.
    Lin HC; Hsiao CH; Ma DH; Yeh LK; Tan HY; Lin MY; Huang SC
    Acta Ophthalmol; 2009 Mar; 87(2):199-203. PubMed ID: 18507727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis.
    Thulasi P; Saeed HN; Rapuano CJ; Hou JH; Appenheimer AB; Chodosh J; Kang JJ; Morrill AM; Vyas N; Zegans ME; Zuckerman R; Tu EY
    Am J Ophthalmol; 2021 Mar; 223():75-82. PubMed ID: 33045218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
    Wysenbeek YS; Blank-Porat D; Harizman N; Wygnanski-Jaffe T; Keller N; Avni I
    Cornea; 2000 Jul; 19(4):464-7. PubMed ID: 10928758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful medical treatment of Acanthamoeba keratitis.
    Azuara-Blanco A; Sadiq AS; Hussain M; Lloyd JH; Dua HS
    Int Ophthalmol; 1997-1998; 21(4):223-7. PubMed ID: 9700010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.
    Polat ZA; Vural A
    Parasitol Res; 2012 May; 110(5):1945-50. PubMed ID: 22160252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of propolis in experimental Acanthamoeba keratitis.
    Vural A; Polat ZA; Topalkara A; Toker MI; Erdogan H; Arici MK; Cetin A
    Clin Exp Ophthalmol; 2007 Nov; 35(8):749-54. PubMed ID: 17997780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
    Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
    Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.
    Duguid IG; Dart JK; Morlet N; Allan BD; Matheson M; Ficker L; Tuft S
    Ophthalmology; 1997 Oct; 104(10):1587-92. PubMed ID: 9331195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of Acanthamoeba keratitis by hexamidine.
    Brasseur G; Favennec L; Perrine D; Chenu JP; Brasseur P
    Cornea; 1994 Sep; 13(5):459-62. PubMed ID: 7995072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis.
    Musayeva A; Riedl JC; Schuster AK; Wasielica-Poslednik J; Pfeiffer N; Gericke A
    Cornea; 2020 Aug; 39(8):986-990. PubMed ID: 32243421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
    Mrva M; Garajová M; Lukáč M; Ondriska F
    J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.